CASS INFORMATION SYSTEMS INC appointed Martin H. Resch as new CEO

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Approval of the 2023 Omnibus Stock and Performance Compensation Plan


At the 2023 Annual Meeting of Shareholders (the "Annual Meeting") of Cass Information Systems, Inc. (the "Company"), held on April 18, 2023 (the "Annual Meeting"), the Company's shareholders approved the Cass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan (the "2023 Omnibus Plan"). The 2023 Omnibus Plan was previously approved by the Company's Board of Directors (the "Board") on February 16, 2023, upon recommendation of the Compensation Committee of the Board, subject to shareholder approval. The 2023 Omnibus Plan has been established to replace, on a prospective basis, the Cass Information Systems, Inc. Amended and Restated Omnibus Stock and Performance Compensation Plan, which was previously approved by shareholders and terminated in accordance with its terms on April 17, 2023.


The 2023 Omnibus Plan permits the grant of stock options (incentive stock options and nonqualified stock options), stock appreciation rights, restricted stock, restricted stock units, phantom stock, and cash-based performance awards. The 2023 Omnibus Plan will be administered by the Compensation Committee of the Board or by its delegate.


A total of 1,000,000 shares of Common Stock, $0.50 per share, is available for grants under the 2023 Omnibus Plan to eligible employees and non-employee directors. The number of shares available for grant is subject to adjustment under certain circumstances described in the 2023 Omnibus Plan.


The Board may terminate or amend the 2023 Omnibus Plan at any time; provided, however, that amendment of the 2023 Omnibus Plan will be subject to shareholder approval in certain circumstances. The 2023 Omnibus Plan will terminate on April 17, 2033. 


This description of the 2023 Omnibus Plan is a summary only and is qualified by reference to the 2023 Omnibus Plan, which is filed as Exhibit 10.1 hereto. A more complete description of the terms of the 2023 Omnibus Plan can be found in section IV, "Approval of the 2023 Omnibus Stock and Performance Compensation Plan - Proposal 4" on pages 17 to 25 of the Company's definitive proxy statement filed with the Securities and Exchange Commission (the "SEC") on March 8, 2023, which description is incorporated by reference herein


Grant of Restricted Stock


As previously announced by the Company, Martin H. Resch was appointed as the Company's Chief Executive Officer effective April 18, 2023 as part of the Company's succession planning. On April 20, 2023, the Board, upon the recommendation of the Compensation Committee, granted Mr. Resch 5,318 shares of restricted stock under the 2023 Omnibus Plan in connection with his transition to Chief Executive Officer. Mr. Resch's restricted stock grant was made in accordance with the terms of the Company's long-term incentive compensation program for executive officers and is in addition to the compensation package previously approved for Mr. Resch as described in the Company's Current Report on Form 8-K filed with the SEC on February 22, 2023. 


The terms of the restricted stock are as set forth in the relevant portions of the Company's form of Restricted Stock Agreement (the "Award Agreement"). Of the total shares awarded, 2,127 are time-based restricted stock that will cliff vest three years from the date of grant and 3,191 are performance-based restricted stock that will vest three years from the date of grant with amounts earned, if any, based on the Company's achievement of earnings per share and return on equity performance targets for the prospective three-year performance period. The ultimate number of performance-based shares earned will range from 0% to 150% of the target award based on the Company's achievement of these performance goals, with no performance-based awards being earned if threshold performance targets are not met. Vesting is accelerated, in certain circumstances, upon termination of employment in the event of death, disability or following a change of control, subject to the terms set forth in the Award Agreement. Time-based restricted stock carries voting and dividend rights from the date of grant; holders of performance-based restricted stock are entitled to voting and dividend rights only upon satisfaction of applicable performance criteria and vesting of the shares. In both cases, the payment of any dividends is deferred until the shares to which such dividends are attributable vest. 


In the event that the Company materially restates its financial statements, the restricted stock shall be subject to rescission, revocation, adjustment, modification or otherwise in accordance with the Company's governing Clawback 


2


Policy, as it may be amended from time to time in compliance with the rules and regulations of the SEC and the Nasdaq Stock Market. 


The summary of the terms of the restricted stock is qualified in its entirety by reference to the terms set forth in the form of the Award Agreement, a copy of which is filed as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference. Further information about the Company's long-term incentive compensation program is discussed in the Company's most recent definitive proxy statement on Schedule 14A, filed with the SEC on March 8, 2023.